Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)
4.090
+0.020 (0.49%)
At close: Apr 22, 2025, 4:00 PM HKT
HKG:6922 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 45.46 | 103.4 | 226.42 | 157.87 | 7.49 |
Short-Term Investments | 0.81 | 1.05 | 1.92 | 1.43 | 0.22 |
Trading Asset Securities | - | - | - | - | 25.52 |
Cash & Short-Term Investments | 46.26 | 104.46 | 228.34 | 159.3 | 33.23 |
Cash Growth | -55.71% | -54.25% | 43.34% | 379.37% | - |
Receivables | 0.06 | 0.13 | 0.08 | 0.25 | 0.38 |
Inventory | 29.87 | 24.35 | 19.93 | 11.7 | 8.1 |
Restricted Cash | 0 | 0.07 | - | - | - |
Other Current Assets | 21.97 | 20.9 | 15.86 | 18.15 | 9.27 |
Total Current Assets | 98.16 | 149.92 | 264.21 | 189.39 | 50.98 |
Property, Plant & Equipment | 38.62 | 51.28 | 41.76 | 38.09 | 20.07 |
Other Intangible Assets | 0 | 0.02 | 0.04 | 0.06 | - |
Other Long-Term Assets | 12.47 | 11.61 | 7.85 | 4.15 | 3.31 |
Total Assets | 149.25 | 212.82 | 313.86 | 231.69 | 74.36 |
Accounts Payable | 1.21 | 1.15 | 1.87 | 0.38 | 0.25 |
Accrued Expenses | 17.05 | 21.68 | 34.77 | 21.07 | 14.19 |
Short-Term Debt | 30 | - | - | - | - |
Current Portion of Leases | 5.6 | 3.25 | 3.43 | 2.6 | 0.45 |
Current Income Taxes Payable | 1.69 | 2.07 | 1.98 | 1.41 | 1.26 |
Current Unearned Revenue | 1.17 | 0.99 | 3.26 | 2.64 | 7.27 |
Other Current Liabilities | 3.11 | 1.64 | 0.42 | 0.2 | 0.07 |
Total Current Liabilities | 59.82 | 30.78 | 45.73 | 28.29 | 23.49 |
Long-Term Leases | 7.72 | 7.76 | 7.94 | 6.41 | 0.13 |
Long-Term Unearned Revenue | 2.78 | 0.82 | 0.8 | - | 0.46 |
Total Liabilities | 70.32 | 39.36 | 54.47 | 34.7 | 24.08 |
Common Stock | 239.11 | 239.11 | 239.11 | 228 | 50.8 |
Additional Paid-In Capital | - | 299.77 | 299.77 | 150.64 | 123.46 |
Retained Earnings | - | -630.96 | -533.48 | -421.25 | -319.38 |
Comprehensive Income & Other | -165.26 | 253.55 | 233.73 | 213.26 | 195.4 |
Total Common Equity | 73.85 | 161.47 | 239.13 | 170.65 | 50.28 |
Minority Interest | 5.08 | 12 | 20.26 | 26.35 | - |
Shareholders' Equity | 78.93 | 173.46 | 259.39 | 197 | 50.28 |
Total Liabilities & Equity | 149.25 | 212.82 | 313.86 | 231.69 | 74.36 |
Total Debt | 43.32 | 11.01 | 11.37 | 9 | 0.58 |
Net Cash (Debt) | 2.94 | 93.44 | 216.97 | 150.3 | 32.65 |
Net Cash Growth | -96.86% | -56.93% | 44.36% | 360.28% | - |
Net Cash Per Share | 0.01 | 0.39 | 0.95 | 0.66 | - |
Filing Date Shares Outstanding | 239.11 | 239.11 | 239.11 | 228 | - |
Total Common Shares Outstanding | 239.11 | 239.11 | 239.11 | 228 | - |
Working Capital | 38.34 | 119.13 | 218.47 | 161.1 | 27.49 |
Book Value Per Share | 0.31 | 0.68 | 1.00 | 0.75 | - |
Tangible Book Value | 73.85 | 161.44 | 239.09 | 170.59 | 50.28 |
Tangible Book Value Per Share | 0.31 | 0.68 | 1.00 | 0.75 | - |
Machinery | - | 37.66 | 34.29 | 29.54 | 27.04 |
Construction In Progress | - | 10.15 | 0.8 | 3.27 | - |
Leasehold Improvements | - | 15.58 | 13.8 | 9.56 | 5.9 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.